The effects of almond consumption on inflammatory biomarkers in adults: A systematic review and meta-analysis of randomized clinical trials

(2021) The effects of almond consumption on inflammatory biomarkers in adults: A systematic review and meta-analysis of randomized clinical trials. Adv Nutr. ISSN 2161-8313

Full text not available from this repository.

Abstract

Conflicting findings have been reported regarding the effects of almond consumption on inflammatory markers. This study aimed to summarize the current literature to determine whether almond can affect inflammatory markers. A systematic search was carried out in PubMed, Scopus, and ISI Web of Science up to March 2021. Randomized clinical trials (RCTs) that compared almond with no almond consumption were included. The outcomes of interest were changes in circulating C-reactive protein (CRP), Interleukin-6 (IL-6), Tumor Necrosis Factor Alpha (TNF-α), Intercellular Adhesion Molecule-1 (ICAM-1) and Vascular Cell Adhesion Molecule-1 (VCAM-1) concentrations. The random-effects model was used to find the mean differences. Totally, 18 trials with 847 participants were eligible for the current analysis. Participant age ranged from 26.3 to 69.6 y. Combining 16 studies, almond consumption significantly reduced serum levels of CRP (WMD: -0.25 mg/L; 95 CI: -0.43, -0.06; I2 = 0.0 P-heterogeneity = 0.633). However, the beneficial effect of almond intake only occurred at doses <60 g/d. Pooling 11 effect sizes, almond interventions significantly decreased circulating IL-6 concentrations (WMD: -0.11 pg/mL; 95 CI: -0.21, -0.01; I2 = 19.9 P-heterogeneity = 0.254). In subgroup analyses, effects on CRP and IL-6 were not significant in unhealthy participants or those with obesity. In addition, almond consumption had no significant effect on TNF-α (WMD: -0.05 pg/mL; 95 CI: -0.11, 0.01; I2 = 0.0 P-heterogeneity = 0.893; n = 6), ICAM-1 (WMD: 6.39 ng/mL; 95 CI: -9.44, 22.22; I2 = 66.6 P-heterogeneity = 0.006; n = 7) or VCAM-1 (WMD: -8.31 ng/mL; 95 CI: -35.32, 18.71; I2 = 58.8 P-heterogeneity = 0.033; n = 6). In conclusion, almond consumption beneficially affects CRP and IL-6 concentrations in adults. However, it has no beneficial effect on TNF-α, ICAM-1, or VCAM-1. More trials are needed to determine the effects of almond on inflammation.

Item Type: Article
Keywords: Almond C-reactive protein Interleukin-6 clinical trial inflammation meta-analysis
Journal or Publication Title: Adv Nutr
Journal Index: Pubmed
Identification Number: https://doi.org/10.1093/advances/nmab158
ISSN: 2161-8313
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/17827

Actions (login required)

View Item View Item